HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: COLIPA in vitro safety testing guidelines

This article was originally published in The Rose Sheet

Executive Summary

COLIPA in vitro safety testing guidelines: European Cosmetic, Toiletry and Perfumery Association "Guidelines for the Safety Assessment of a Cosmetic Product" demonstrate how "finished products can be assessed for their safety [while] avoiding new product testing" on animals, the document states. The guidelines were developed with an eye toward small- and medium-sized cosmetics companies that may not have access to extensive R&D facilities, the trade group noted. Recommendations for appropriate in vitro tests are made in the guidelines; for example, COLIPA suggests the use of five in vitro ocular tests for finished products, including the Tissue Equivalent Assay and Fluorescein Leakage Test. The guidelines also set forth the responsibilities of the safety assessor as required by the European Union Cosmetics Directive. The document was prepared in response to the proposed 7th Amendment to the Cosmetic Directive, which bans animal testing on finished products. The guidelines are available through COLIPA...

COLIPA in vitro safety testing guidelines: European Cosmetic, Toiletry and Perfumery Association "Guidelines for the Safety Assessment of a Cosmetic Product" demonstrate how "finished products can be assessed for their safety [while] avoiding new product testing" on animals, the document states. The guidelines were developed with an eye toward small- and medium-sized cosmetics companies that may not have access to extensive R&D facilities, the trade group noted. Recommendations for appropriate in vitro tests are made in the guidelines; for example, COLIPA suggests the use of five in vitro ocular tests for finished products, including the Tissue Equivalent Assay and Fluorescein Leakage Test. The guidelines also set forth the responsibilities of the safety assessor as required by the European Union Cosmetics Directive. The document was prepared in response to the proposed 7th Amendment to the Cosmetic Directive, which bans animal testing on finished products. The guidelines are available through COLIPA....

Latest Headlines
See All
UsernamePublicRestriction

Register

RS004771

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel